Company research / ANGO

Angiodynamics Inc (ANGO)

SEC name ANGIODYNAMICS INC · CIK 0001275187 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends May 31

For the year ended 2026-05-31, Angiodynamics Inc reported revenue of $320.17M. Revenue grew 9.5% from the prior annual period. Over the twelve months to 2026-08-31, revenue was $325.38M.

Key ratios (year ended 2026-05-31)

54.6%
Gross margin
-12.5%
Operating margin
-11.5%
Net margin
-21.5%
Return on year-end equity
9.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-10-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-08-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-08-31
2026-05-312025-05-312024-05-312023-05-312022-05-312021-05-312020-05-312019-05-312018-05-312017-05-31
Revenue$325.38M$320.17M$292.50M$303.91M$338.75M$316.22M$291.01M$264.16M$270.63M$261.65M$269.79M
Cost of Revenue$144.30M$145.28M$134.79M$149.22M$164.51M$150.49M$134.22M$113.89M$114.63M$117.80M$125.84M
Gross Profit$181.07M$174.89M$157.71M$154.70M$174.25M$165.73M$156.79M$150.27M$156.00M$143.86M$143.95M
R&D Expense$31.01M$29.45M$26.22M$31.51M$29.88M$30.74M$36.39M$29.68M$28.26M$24.34M$24.15M
Operating Income-$36.57M-$39.93M-$39.95M-$192.44M-$51.18M-$28.47M-$35.28M-$167.10M-$9.40M-$14.17M-$11.18M
Depreciation & Amortizationn/a$22.95M$25.80M$27.71M$30.87M$29.35M$25.92M$23.80M$25.88M$23.16M$24.81M
EBITDAn/a-$16.97M-$14.15M-$164.72M-$20.31M$878.0K-$9.37M-$143.29M$16.48M$8.99M$13.64M
Net Income-$32.94M-$36.74M-$33.99M-$184.35M-$52.44M-$26.55M-$31.55M-$166.79M$61.34M$16.34M$5.01M
EPS (Diluted)n/a-$0.88-$0.83-$4.59-$1.33-$0.68-$0.82-$4.39$1.64$0.44$0.14
Total Assets$241.93M$267.16M$280.14M$317.67M$532.64M$552.75M$561.44M$594.21M$836.44M$705.47M$707.96M
Total Liabilities$77.97M$96.34M$97.17M$112.08M$154.34M$128.26M$121.98M$139.34M$221.62M$162.88M$192.93M
Long-Term Debtn/an/an/a$0$49.82M$25.00Mn/an/a$131.91M$91.62M$96.32M
Shareholders' Equity$163.96M$170.82M$182.97M$205.59M$378.30M$424.49M$439.46M$454.87M$614.82M$542.60M$515.03M
Cash & Equivalents$33.97M$53.86M$55.89M$76.06M$44.62M$28.82M$48.16M$54.44M$227.64M$74.10M$47.54M
Operating Cash Flow$3.67M$3.09M-$10.13M-$28.16M$78.0K-$7.19M$24.09M-$14.55M$37.44M$41.29M$55.74M
Capital Expenditures$2.23M$2.58M$4.46M$2.52M$3.81M$4.30M$5.19M$7.24M$3.12M$2.39M$3.00M
Free Cash Flow$1.44M$508.0K-$14.59M-$30.68M-$3.73M-$11.49M$18.91M-$21.79M$34.32M$38.90M$52.74M
Share Repurchasesn/a$0$1.67M$0$0n/an/an/a$0$0$13.56M
Shares Outstanding42.42M41.70M40.99M40.43M39.61M39.17M38.55M38.08M37.61M37.22M36.84M
Weighted Average Diluted Sharesn/a41.53M40.85M40.18M39.48M39.01M38.34M37.96M37.48M37.07M36.62M
EPS (Basic)n/a-$0.88-$0.83-$4.59-$1.33-$0.68-$0.82-$4.39$1.64$0.44$0.14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView